Terapeutisk cancervaccination mod hæmatologisk cancer

Translated title of the contribution: Therapeutic cancer vaccination for treatment of haematological cancers

Morten Orebo Holmström, Jacob Handlos Grauslund, Nicolai Grønne Dahlager-Jørgensen, Uffe Klausen, Hans Carl Hasselbalch, Mads Hald Andersen


Few trials testing the clinical efficacy of therapeutic cancer vaccination have been successful, and therapeutic cancer vaccines are yet to enter the clinic for treatment of haematological cancers. The review summarises the present knowledge of the interplay between cancer and the immune system. These novel insights have uncovered knowledge, which can be used to enhance the effect of therapeutic cancer vaccines in haematology. Immune checkpoint inhibitors, immunomodulating agents, radiotherapy and vaccination against regulatory mechanisms can potentially increase the clinical effect of cancer vaccines for haematological cancer.

Translated title of the contributionTherapeutic cancer vaccination for treatment of haematological cancers
Original languageDanish
JournalUgeskrift for Laeger
Issue number20A
Publication statusPublished - 14 Oct 2019


Dive into the research topics of 'Therapeutic cancer vaccination for treatment of haematological cancers'. Together they form a unique fingerprint.

Cite this